1. Introduction {#sec1}
===============

Cardiovascular disease (CVD) and chronic kidney disease (CKD) are two important global public health concerns that share common cardiometabolic risk factors that include hypertension, diabetes mellitus, and hyperlipidemia. The above three diseases generally coexist, making them the most common risk factors for CVD \[[@B1]\]. In 2007, the Taiwan Health Promotion Administration of the Ministry of Health and Welfare conducted a survey involving 5,895 healthy individuals in Taiwan and concluded that, among those patients with hypertension, diabetes mellitus, and hyperlipidemia, their rates of developing heart disease in 5 years are 1.9, 1.5, and 1.8 times greater than those without hypertension, diabetes mellitus, and hyperlipidemia, respectively \[[@B2]\]. Cardiovascular events include fatal and nonfatal cardiovascular events (stroke, infarction, angina, and heart failure). Hypertension, diabetes mellitus, and hyperlipidemia contribute to the increased risk of experiencing cardiovascular events \[[@B3]\]. It is suggested that patients who currently have CVD or have received coronary revascularization should take steps to mitigate their cardiovascular risks \[[@B4]\].

Hypertension, diabetes mellitus, and hyperlipidemia are also initiation factors for CKD \[[@B5]\]. One study showed that mild renal insufficiency was common among community-based citizens and that this condition was related to the high prevalence of CVD. Mild renal insufficiency increases the risk of cardiovascular events and total mortality \[[@B6]\]. It was reported that a lower estimated glomerular filtration rate (eGFR) correlates with a higher risk of cardiovascular events and the related death \[[@B7]\]. Microvascular abnormality is a common triggering factor for both CVD and CKD \[[@B8]\]. The Kidney Early Evaluation Program study suggested that conditions for cardiovascular risk are defined as a urine albumin: creatinine ratio ≥30 mg/g (3.4 mg/mmol) or an eGFR \< 60 mL/min/1.73 m^2^ \[[@B7]\].

The main complication of CKD is CVD. Observations made in the Kidney Early Evaluation Program and the National Health and Nutrition Examination Survey studies suggested that CKD may increase the prevalence of myocardial infarction or stroke \[[@B8]\]. Medium to severe renal function impairments exacerbate atherosclerosis, which in turn leads to an increased risk of cardiovascular events \[[@B9]\]. This means the deaths of CKD patients are more likely caused by CVD than by progression of kidney failure \[[@B10]\]. However, patients with CVD also suffer from a higher risk of CKD \[[@B11]\]. Patients who have undergone coronary revascularization must be aware of their potential CKD risk for the future. That CKD may also cause atherosclerosis in coronary arteries and the cerebrovascular and peripheral circulatory system \[[@B12]\]. Additionally, the coexistence of CVD and CKD leads to higher mortality \[[@B6]\]. Therefore, CVD and CKD should be considered mutual risk factors for each other. Among CVD patients the CKD prevention is necessary, and similar condition is conversely alike. Therefore, development of an indicator that predicts the risk of both conditions would help to effectively treat the coexistence of both diseases.

Abdominal obesity and general obesity would cause increases in triglycerides, low density lipoprotein (LDL) cholesterol, blood sugar, insulin, and blood pressures. They will also cause decreases in high density lipoprotein (HDL) cholesterol. All of these factors may lead to onset of CVD, which in turn increases coronary heart disease onset or mortality and total mortality \[[@B13], [@B14]\]. Neck circumference (NC) is an indicator of upper body fat distribution, whereas body morphologies and fat distribution can be used as factors to assess the risk of obesity \[[@B15]\]. In addition to body mass index (BMI), waist circumference, and hip circumference measurements as indicators of obesity, NC can also be used as a novel indicator for cardiometabolic risk \[[@B16], [@B17]\]. However, previous studies have not focused on NC with CKD. This pilot study aimed to investigate the relationship between NC and CKD. We intend to confirm whether NC is as an associated indicator of CKD for high cardiovascular risk patients or whether it is as an alternative option for disabled or bedbound patients for whom other body anthropometric indicator measurements are not suitable.

2. Materials and Methods {#sec2}
========================

2.1. Research Framework and Participants {#sec2.1}
----------------------------------------

This study, as given in [Figure 1](#fig1){ref-type="fig"}, involved 177 patients with cardiovascular risk. Inclusion criteria were patients aged \>20 years with normal renal function or with stages 1\~4 CKD, excluding conditions such as acute renal failure, inherited kidney diseases, nephritic syndrome, cancer, and long-term use of steroid. This study was approved by the Institute Review Committees at Tri-Service General Hospital and Chiayi Chang Gung Memorial Hospital and all the participants signed informed consent prior to study enrolment.

2.2. Data Collection {#sec2.2}
--------------------

Patients\' demographic characteristics were obtained via face-interviewed questionnaires. Blood pressure and anthropometric measures, such as height, weight, NC, waist circumference, and hip circumference, were measured. Laboratory parameters were assessed for urine and fasting blood samples, which were collected in the same day. Creatinine concentration was determined using the Modified Jaffe Method with a SYNCHRON LXI 725 (Tokyo, Japan) instrument; cystatin C concentration was determined using a particle-enhanced turbid metric immunoassay with a Hitachi 7170 (Tokyo, Japan) instrument.

2.3. Assessment of Renal Function {#sec2.3}
---------------------------------

GFR was calculated based on the 24-hour urine creatinine clearance rate (24 hr CCR) to assess renal function. The equation for 24 hr CCR is as follows: (24 hr urine total volume × urine creatinine concentration)/(creatinine concentration × 1440). The eGFR calculation was based on Modification of Diet in Renal Disease (MDRD), as eGFR~MDRD~ = 186 × crea^−1.154^ × age^−0.203^ × (0.742 if female) × (1.212 if black), and Cockcroft-Gault Equation (CG), as eGFR~CG~ = \[(140 − age) × weight (kg)\] ÷ (creatinine (mg/dL) × 72) × (0.85 if female).

2.4. Data Processing {#sec2.4}
--------------------

All data were grouped by gender or age. A *t*-test was performed to assess the differences between ages within the same gender groups. The relevance between NC and each laboratory measurement was assessed using the Spearman correlation analysis. Continuous data for males and females were analyzed separately using the Kolmogorov-Smirnov test or the Shapiro-Wilk test for normal distribution. If data were not normally distributed, logarithmic transformation of the data was performed to make the data fit a normal distribution. To investigate the relevance between anthropometric measures and heart disease and CKD risk factors, a linear regression was performed using the Enter method to present an unadjusted *R* ^2^, standardized coefficients, and standard error, and the Durbin-Watson test was used to assess residual independence. An age adjustment was made for all assessed cardiovascular risk factors. To avoid the impact of renal function differences in individuals, age and log(creatinine) were included to correct the risk factors assessment. All statistical analyses were performed using SPSS 18.0 (Statistical Package for Social Sciences, Chicago, IL, USA). A *P* value \< 0.05 was considered a statistically significant level.

3. Results {#sec3}
==========

The characteristics of 177 participants in this study are presented in [Table 1](#tab1){ref-type="table"}. There were 122 (71%) males with a mean age of 66 and 50 (29%) females with a mean age of 67. For most anthropometric measures, the measurements from patients ≧ 65 years old were lower than those from patients \< 65 years old, except for women\'s waist circumference and waist hip ratio. Differences were observed in weight, BMI, diastolic blood pressure, triglycerides, serum creatinine, cystatin C, phosphorus, 24 hr CCR, eGFR~MDRD~, and eGFR~CG~ between different ages among males. In each age of females, the differences were observed in height, weight, BMI, hip circumference, waist hip ratio, NC, cystatin C, albumin, urine creatinine, 24 hr CCR, and eGFR~CG~. Elderly patients of both genders typically perform a poor renal function.

[Table 2](#tab2){ref-type="table"} showed the Spearman correlation coefficients with NC between both sexes. In males, most relevant coefficients were significant, especially those anthropometric measures, fasting glucose, triglycerides, cystatin C, aspartate aminotransferase, 24 hr CCR, and eGFR~CG~, where positive correlations were observed between NC and 24 hr CCR, eGFR~CG~, hsCRP, triglycerides, and LDL cholesterol. In females, diastolic blood pressure, triglycerides, uric acid, albumin, high-sensitivity C-reactive protein (hsCRP), total protein, phosphorus, and eGFR~CG~ reached significance, where negative correlations were observed between NC and total cholesterol, HDL, total protein, aspartate aminotransferase, alanine aminotransferase, phosphorus, sodium, and potassium.

Regression curves after age adjustment are shown in [Table 3(a)](#tab3){ref-type="table"}. Compared to BMI, waist circumference, and hip circumference, the higher *R* ^2^ values were obtained for female NC and microalbuminuria, hsCRP, triglycerides, and HDL cholesterol. Age- and log(creatinine)-adjusted curves are shown in [Table 3(b)](#tab3){ref-type="table"}. The items showing statistical significance in male and female NC are roughly the same as those in [Table 3(a)](#tab3){ref-type="table"}. Female NC was adjusted for age and log(creatinine), the significance of 24 hr CCR and uric acid was improved. Compared to BMI, waist circumference, and hip circumference, the highest *R* ^2^ values were obtained for female NC and 24 hr CCR, uric acid, microalbuminuria, hsCRP, triglycerides, and HDL cholesterol (negative correlation).

4. Discussion {#sec4}
=============

Several studies have revealed the relationship between body adipose abnormalities, CVD, and metabolic syndrome \[[@B16]--[@B29]\] as well as between cardiometabolic factors and CKD \[[@B1], [@B4], [@B5], [@B7]--[@B11], [@B30], [@B31]\]. However, there is lack of reporting on the relevance between NC and CKD. This is the first study to report their relationship and it is discovered that NC is associated with indicators of renal disease such as 24 hr CCR, eGFR~CG~, uric acid, and urine microalbuminuria, in addition to conventional cardiovascular risk factors such as hsCRP, triglycerides, LDL cholesterol, and HDL cholesterol.

NC is an alternative measurement for upper-body subcutaneous fat, and therefore NC may play a vital role in CVD clinical prediction \[[@B16]\]. NC as an associated factor for diabetes, after adjusted BMI and waist circumference, was the only risk factor related to type II diabetes mellitus \[[@B26]\]. These results confirmed that NC measurements can be used as an effective clinical screening tool for insulin resistance, and can be used as powerful indicators to improve the screening ability for type II diabetes mellitus. In addition to insulin resistance and type II diabetes mellitus, NC also has associated power to assess cardiometabolic risk \[[@B28]\].

NC also correlated significantly with intima-media thickness of common or internal carotid arteries after BMI and waist circumference adjustment. For every 1-standard deviation unit increase in NC, there is a 0.025 mm thickness increase in common carotid artery, and remaining significant even after BMI adjustment \[[@B27]\]. In a follow-up study involving acute ischemic stroke patients who have a 1-year total mortality of 8.9%, the author discovered that aging and larger neck circumference were more frequent findings among the dead, but not obesity. Therefore, NC is a critical clinical warning factor for fatal outcomes in acute ischemic stroke \[[@B25]\]. Insulin resistance, related with NC, causes arterial stiffness, which in turn has an impact on CKD and even nondiabetic CKD. CKD patients who develop metabolic syndrome would also have a higher risk of arterial stiffness \[[@B30]\].

Although gender differences of anthropometric measures, systolic blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, and fasting plasma glucose exist, NC is also related to cardiometabolic risk \[[@B16]\] and is a powerful indicator for predicting dyslipidemia. In particular, the correlation between triglycerides and NC is stronger than BMI and waist circumference \[[@B28]\]. Moreover, the relevance and importance of waist circumference and metabolic syndrome to CVD have been discussed previously \[[@B32]\]. One study showed that dual indicators using both triglycerides and waist circumference can assess the risk of coronary artery disease in patients with abdominal obesity. When the Framingham model was used for predicting CVD risk, these dual indicators may help to add associated value. The hypertriglyceridemic-waist phenotype might become a superior health indicator compared to metabolic syndrome \[[@B33]\]. Another study in CKD patients suggested that the hypertriglyceridemic-waist phenotype can be used to evaluate the severity of carotid atherosclerosis and can also be used as an effective indicator to predict CVD risk \[[@B31]\]. Our study showed NC is highly correlated to waist circumference and triglycerides. Therefore, NC may replace waist circumference for phenotyping, especially because this phenotype can be used for both coronary heart disease and CKD. NC is an ideal associated indicator for these two coexisting diseases that are risk factors for each other. Moreover, for patients who are disabled, in serious condition, in particular those who are bedridden, or even in healthy status, this method would be not only simple but also easy to perform with high efficiency and convenience. Therefore, NC may be popularized for clinical applications as an associated indicator of risk for both outcomes.

Based on the eGFR~CG~ equation, we know that weight and eGFR are positively correlated. Specifically, heavier weights correlate with higher eGFR~CG~ among those with the same sex, age, and creatinine level. From [Table 2](#tab2){ref-type="table"} in this study, we can conclude that NC and weight are positively correlated. Subjects aged \<65 years have higher mean NC values and also have higher mean eGFR~CG~ values and eGFR~MDRD~, indicating that patients with higher NC values usually have better renal function. This means that NC is positively correlated with eGFR. The eGFR~MDRD~ and eGFR~CG~ equations had the gender-specific coefficient of creatinine.

Hoebel et al. have established the cutoffs for NC to evaluate the risk of metabolic syndrome, which were 40 cm and 41 cm for the young and older men, 34 cm and 33 cm for young and older women, respectively \[[@B22]\], which indicates potential uses of NC for other purposes. Body morphologies, other than NC, have an existing normal level; out of which indicate unhealthy conditions. Appropriate cut-off values for NC should be established, in the future, to assess early stage risk of CKD. This cross-sectional study relied on hospital-based samples. It is suggested that a future population-based study and a cohort-based study with follow-up should be conducted, so that the importance of NC to the CKD risk prediction can be validated, and it can be determined whether this importance will change with increasing age. However, in fashion experience and healthy population, the circumference of someone\'s neck would be about the same as his/her pants width; that is, the waist circumference is about twice the neck circumference \[[@B34]\]. Several studies report similar ratios around 1.9 to 2.1 for circumferences of waist to neck in control groups \[[@B16], [@B17], [@B21], [@B22], [@B29]\].

Many indicators are testing for obesity and NC is an anthropometric measure of obesity for upper subcutaneous adipose tissue distribution which is associated with cardiometabolic risk, while NC is an alternative and novel indicator to test body fat distribution \[[@B17]\], and it is also a simple and time-saving screening tool to capture overweight or obese patient \[[@B20]\]. NC also is an easy associated tool for metabolic syndrome and insulin resistance \[[@B22]\] and a powerful indicator of atherosclerotic lipid abnormalities and their risk factors \[[@B17]\]. NC is also an independent associated factor for cardiometabolic risk \[[@B16], [@B29]\] and an effective screening test for cardiovascular risk in children \[[@B18]\] or even in obese children \[[@B23]\]. Studies mentioned above have suggested that NC is a superior indicator for metabolic syndrome in terms of both relevance and significance compared to BMI and waist circumference \[[@B17], [@B19], [@B21], [@B24], [@B28], [@B35], [@B36]\].

5. Conclusions {#sec5}
==============

NC is associated with indicators of CKD for high cardiometabolic risk patients and can be routinely measured as easy as WC in the future.
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###### 

Study characteristics by sex and age.

  Variables, mean (SD)               Men, *n* = 125   Women, *n* = 52                                           
  ---------------------------------- ---------------- ----------------- --------- -------------- -------------- ---------
  Age (yrs)                          58 (5.2)         73.7 (5.3)        \<0.001   58.6 (5.5)     75.1 (6)       \<0.001
  Height (cm)                        166.2 (6.1)      164.8 (4.8)       0.166     157 (5.7)      153 (5.8)      0.015
  Weight (kg)                        76.8 (11.8)      70.8 (10.4)       0.003     68.9 (12)      59.7 (8.6)     0.002
  Body mass index (kg/m^2^)          27.7 (3.5)       26 (3.7)          0.011     27.9 (4)       25.5 (3)       0.017
  Waist circumference (cm)           97.3 (9.7)       94.5 (9.3)        0.104     92.3 (11.3)    95.8 (9.2)     0.230
  Hip circumference (cm)             101.8 (7.2)      100.2 (7.2)       0.224     102.3 (10.4)   97.5 (5.9)     0.049
  Waist hip ratio                    1 (0.1)          0.9 (0.1)         0.198     0.9 (0.1)      1 (0.1)        0.001
  Neck circumference (cm)            40.6 (3.3)       39.6 (3.3)        0.100     36.6 (2.9)     34.7 (2.6)     0.017
  Systolic blood pressure (mmHg)     137.3 (12.3)     136.4 (16.1)      0.732     132.1 (12)     133.9 (11.7)   0.588
  Diastolic blood pressure (mmHg)    79.9 (6.7)       76.8 (8.9)        0.030     78 (8)         73.9 (8.3)     0.073
  Fasting glucose (mg/dL)            119.5 (44.2)     110.9 (27)        0.205     111.3 (30.5)   112.5 (27.6)   0.883
  Total cholesterol (mg/dL)          183.2 (34.5)     181.2 (32.2)      0.748     205.6 (41.1)   197.8 (29.4)   0.448
  LDL cholesterol (mg/dL)            114.5 (29.9)     114.5 (27.1)      0.990     123.5 (37.1)   112.9 (27.4)   0.258
  HDL cholesterol (mg/dL)            44.3 (7.8)       46.5 (15.4)       0.315     53.9 (12.9)    49.9 (11.3)    0.258
  Triglyceride (mg/dL)               148.5 (74.4)     117.1 (46.9)      0.006     137.9 (80.1)   136.3 (53.4)   0.937
  Serum creatinine (mg/dL)           1.1 (0.3)        1.3 (0.5)         0.011     0.9 (0.2)      1 (0.4)        0.584
  Cystatin C (mg/L)                  0.9 (0.2)        1.2 (0.4)         \<0.001   0.9 (0.2)      1.1 (0.3)      0.024
  Blood urea nitrogen (mg/dL)        17.9 (6.3)       20.2 (7.2)        0.075     16.9 (4.8)     18.9 (10.1)    0.373
  Uric acid (mg/dL)                  7 (1.6)          6.9 (1.4)         0.908     6 (1.6)        6.2 (1.5)      0.632
  Albumin (mg/dL)                    4.4 (0.5)        4.4 (0.3)         0.437     4.4 (0.3)      4.3 (0.2)      0.046
  hsCRP (mg/L)                       2 (2)            1.6 (2.2)         0.319     2.1 (2.5)      2.1 (2.7)      0.992
  Microalbuminuria (mg/day)          23.4 (33)        29.5 (61.1)       0.505     29.2 (54.8)    17.6 (34.6)    0.377
  Total protein (mg/dL)              7.4 (0.5)        7.6 (0.5)         0.094     7.7 (0.5)      7.5 (0.4)      0.138
  Aspartate aminotransferase (U/L)   28.9 (23.1)      30.7 (30.2)       0.721     25.4 (10.6)    26.3 (20.3)    0.842
  Alanine aminotransferase (U/L)     35.7 (31.2)      33.8 (37.4)       0.753     35.7 (30.9)    23 (18.7)      0.085
  Alkaline phosphatase (U/L)         63.6 (24.4)      61.4 (15.1)       0.777     65.7 (15.1)    64 (33.1)      0.912
  Calcium (mg/dL)                    8.8 (0.5)        8.7 (0.5)         0.655     8.7 (0.5)      8.8 (0.7)      0.547
  Phosphorus (mmol/L)                3.5 (0.4)        3.2 (0.5)         0.012     3.8 (0.3)      3.7 (0.5)      0.175
  Sodium (mmol/L)                    143.7 (2)        143.2 (2.2)       0.200     144.4 (2)      143.8 (2)      0.299
  Potassium (mEq/L)                  4.9 (5.3)        4.9 (5.4)         0.953     5.8 (8.1)      6.4 (9.1)      0.842
  Bilirubin (mg/dL)                  1.1 (1.4)        0.9 (0.5)         0.233     0.8 (0.2)      0.8 (0.3)      0.194
  Urine creatinine (mg/dL)           74.6 (28.7)      79.7 (36.2)       0.395     71.9 (30.9)    56.1 (17.9)    0.034
  24 hr CCR (mL/min)                 103.3 (33.1)     78.1 (31.7)       \<0.001   93 (33.3)      67.8 (25.9)    0.004
  eGFR~MDRD~ (mL/min/1.73 m^2^)      75.1 (18.9)      62.1 (17.5)       \<0.001   72.6 (20)      67 (19)        0.319
  eGFR~CG~ (mL/min/1.73 m^2^)        81.7 (23.6)      53.7 (16.5)       \<0.001   76.8 (23.8)    52 (15.2)      \<0.001

###### 

Spearman correlation coefficients of neck circumference by sex and age.

  Variables                          Men \< 65 yrs (*n* = 57)   Men ≧ 65 yrs (*n* = 68)   Women \< 65 yrs (*n* = 26)   Women ≧ 65 yrs (*n* = 26)                               
  ---------------------------------- -------------------------- ------------------------- ---------------------------- --------------------------- -------- --------- -------- ---------
  Age (yrs)                          −0.263                     0.048                     −0.113                       0.361                       −0.373   0.060     0.167    0.414
  Height (cm)                        0.125                      0.355                     0.149                        0.224                       0.552    0.003     0.255    0.209
  Weight (kg)                        0.677                      \<0.001                   0.649                        \<0.001                     0.635    \<0.001   0.760    \<0.001
  Body mass index (kg/m^2^)          0.738                      \<0.001                   0.643                        \<0.001                     0.417    0.034     0.668    \<0.001
  Waist circumference (cm)           0.665                      \<0.001                   0.712                        \<0.001                     0.331    0.098     0.622    0.001
  Hip circumference (cm)             0.660                      \<0.001                   0.743                        \<0.001                     0.560    0.003     0.832    \<0.001
  Waist hip ratio                    0.342                      0.009                     0.337                        0.005                       −0.054   0.794     0.114    0.579
  Systolic blood pressure (mmHg)     0.059                      0.665                     0.230                        0.059                       0.159    0.438     0.185    0.365
  Diastolic blood pressure (mmHg)    0.141                      0.295                     0.229                        0.060                       0.648    \<0.001   −0.170   0.406
  Fasting glucose (mg/dL)            0.125                      0.356                     0.339                        0.006                       −0.027   0.899     0.092    0.662
  Total cholesterol (mg/dL)          0.222                      0.097                     0.104                        0.409                       −0.170   0.418     −0.032   0.879
  LDL cholesterol (mg/dL)            0.227                      0.089                     0.223                        0.074                       −0.229   0.271     0.193    0.356
  HDL cholesterol (mg/dL)            0.099                      0.464                     −0.181                       0.156                       −0.274   0.185     −0.261   0.218
  Triglyceride (mg/dL)               0.176                      0.191                     0.339                        0.006                       0.295    0.152     0.423    0.044
  Creatinine (mg/dL)                 −0.167                     0.215                     −0.076                       0.546                       0.057    0.788     −0.036   0.866
  Cystatin C (mg/L)                  0.303                      0.034                     −0.100                       0.450                       0.276    0.226     −0.041   0.863
  Blood urea nitrogen (mg/dL)        −0.040                     0.773                     0.116                        0.377                       −0.090   0.668     0.318    0.121
  Uric acid (mg/dL)                  −0.202                     0.135                     0.113                        0.374                       0.630    0.001     0.140    0.505
  Albumin (mg/dL)                    0.057                      0.674                     0.082                        0.521                       0.268    0.195     −0.397   0.050
  hsCRP (mg/L)                       0.188                      0.174                     0.244                        0.058                       0.627    0.001     0.053    0.806
  Microalbuminuria (mg/day)          0.238                      0.077                     0.049                        0.709                       0.380    0.067     0.256    0.217
  Total protein (mg/dL)              0.044                      0.745                     0.078                        0.541                       −0.040   0.849     −0.607   0.001
  Aspartate aminotransferase (U/L)   0.003                      0.982                     −0.314                       0.012                       −0.011   0.957     −0.161   0.443
  Alanine aminotransferase (U/L)     0.028                      0.834                     0.089                        0.482                       −0.020   0.925     −0.044   0.833
  Alkaline phosphatase (U/L)         0.443                      0.172                     0.185                        0.526                       −0.319   0.538     0.559    0.192
  Calcium (mg/dL)                    −0.018                     0.895                     0.157                        0.215                       0.260    0.209     0.171    0.414
  Phosphorus (mmol/L)                −0.121                     0.373                     −0.013                       0.918                       −0.221   0.288     −0.432   0.031
  Sodium (mmol/L)                    0.070                      0.606                     0.117                        0.357                       −0.134   0.524     −0.237   0.255
  Potassium (mEq/L)                  0.001                      0.995                     0.261                        0.067                       −0.055   0.818     −0.026   0.915
  Bilirubin (mg/dL)                  0.001                      0.997                     −0.041                       0.746                       0.277    0.180     −0.116   0.581
  Urine creatinine (mg/dL)           0.165                      0.220                     0.037                        0.770                       0.249    0.230     −0.011   0.958
  24 hr CCR (mL/min)                 0.440                      0.001                     0.296                        0.017                       0.231    0.267     0.064    0.760
  eGFR~MDRD~ (mL/min/1.73 m^2^)      0.216                      0.107                     0.077                        0.541                       −0.066   0.752     0.039    0.852
  eGFR~CG~ (mL/min/1.73 m^2^)        0.475                      \<0.001                   0.355                        0.004                       0.341    0.095     0.442    0.027

###### 

\(a\) Age adjusted linear regression of CVD and CKD risk among body shape indicators. (b) Age- and log(creatinine)-adjusted linear regression of CVD and CKD risk among body shape indicators.

  Dependent variables             Men (*n* = 125)   Women (*n* = 52)                                        
  ------------------------------- ----------------- ------------------ --------- ------- ------------------ ---------
  24 hr CCR                                                                                                  
   log⁡(Neck circumference)       0.279             269.32 (76.68)     0.001     0.232   114.479 (122.29)   0.243
   log⁡(Body mass index)          0.290             181.14 (47.90)     \<0.001   0.211   −26.755 (73.81)    0.719
   log⁡(Waist circumference)      0.310             268.82 (62.92)     \<0.001   0.210   −13.095 (87.87)    0.882
   log⁡(Hip circumference)        0.337             412.97 (84.67)     \<0.001   0.210   −30.973 (117.5)    0.793
  eGFR~CG~                                                                                                   
   log⁡(Neck circumference)       0.524             206.02 (44.09)     \<0.001   0.503   163.779 (71.69)    0.027
   log⁡(Body mass index)          0.591             172.49 (25.72)     \<0.001   0.534   121.746 (41.36)    0.005
   log⁡(Waist circumference)      0.601             237.27 (33.85)     \<0.001   0.531   142.509 (49.32)    0.006
   log⁡(Hip circumference)        0.588             312.44 (47.22)     \<0.001   0.576   236.87 (62.72)     \<0.001
  eGFR~MDRD~                                                                                                 
   log⁡(Neck circumference)       0.140             20.87 (46.60)      0.655     0.081   −50.119 (81.36)    0.541
   log⁡(Body mass index)          0.144             25.1 (29.26)       0.393     0.130   −82.537 (47.14)    0.086
   log⁡(Waist circumference)      0.150             49.83 (38.86)      0.202     0.084   −42.682 (57.52)    0.462
   log⁡(Hip circumference)        0.157             85.06 (53.13)      0.112     0.096   −82.797 (76.46)    0.284
  log⁡(Cystatin C)                                                                                           
   log⁡(Neck circumference)       0.179             0.43 (0.31)        0.166     0.210   0.131 (0.49)       0.789
   log⁡(Body mass index)          0.166             −0.09 (0.19)       0.624     0.313   0.635 (0.26)       0.021
   log⁡(Waist circumference)      0.166             0.15 (0.26)        0.571     0.263   0.543 (0.33)       0.104
   log⁡(Hip circumference)        0.169             0.29 (0.36)        0.419     0.254   0.634 (0.42)       0.139
  Uric Acid                                                                                                  
   log⁡(Neck circumference)       0.009             −3.75 (3.99)       0.349     0.188   19.258 (6.05)      0.003
   log⁡(Body mass index)          0.002             0.02 (2.45)        0.993     0.216   12.354 (3.54)      0.001
   log⁡(Waist circumference)      0.002             −0.41 (3.28)       0.901     0.111   10.223 (4.48)      0.027
   log⁡(Hip circumference)        0.014             −5.39 (4.48)       0.231     0.149   16.098 (5.87)      0.009
  log⁡(Urine microalbuminuria)                                                                               
   log⁡(Neck circumference)       0.021             2.36 (1.51)        0.120     0.200   7.255 (2.16)       0.002
   log⁡(Body mass index)          0.093             3.14 (0.92)        0.001     0.105   3.089 (1.35)       0.027
   log⁡(Waist circumference)      0.058             3.26 (1.23)        0.009     0.110   3.764 (1.6)        0.023
   log⁡(Hip circumference)        0.049             4.09 (1.70)        0.017     0.06    3.661 (2.19)       0.102
  log⁡(hsCRP)                                                                                                
   log⁡(Neck circumference)       0.048             2.98 (1.40)        0.036     0.101   4.366 (1.96)       0.031
   log⁡(Body mass index)          0.062             2.13 (0.85)        0.014     0.067   2.091 (1.18)       0.084
   log⁡(Waist circumference)      0.055             2.66 (1.14)        0.022     0.063   2.407 (1.41)       0.094
   log⁡(Hip circumference)        0.043             3.15 (1.59)        0.049     0.095   3.995 (1.86)       0.037
  log⁡(Systolic blood pressure)                                                                              
   log⁡(Neck circumference)       0.015             0.14 (0.12)        0.252     0.025   0.175 (0.16)       0.292
   log⁡(Body mass index)          0.042             0.16 (0.07)        0.031     0.003   −0.006 (0.1)       0.951
   log⁡(Waist circumference)      0.031             0.18 (0.10)        0.068     0.006   0.049 (0.12)       0.674
   log⁡(Hip circumference)        0.036             0.27 (0.14)        0.047     0.006   0.061 (0.16)       0.698
  Diastolic blood pressure                                                                                   
   log⁡(Neck circumference)       0.105             27.44 (19.94)      0.171     0.260   31.523 (30.9)      0.313
   log⁡(Body mass index)          0.157             37.4 (12.09)       0.002     0.045   −4.045 (18.69)     0.830
   log⁡(Waist circumference)      0.114             29.63 (16.58)      0.076     0.273   29.645 (21.42)     0.173
   log⁡(Hip circumference)        0.123             48.09 (22.66)      0.036     0.260   29.157 (29.33)     0.325 
  log⁡(Fasting plasma glucose)                                                                               
   log⁡(Neck circumference)       0.023             0.48 (0.29)        0.100     0.013   0.142 (0.41)       0.731
   log⁡(Body mass index)          0.055             0.47 (0.18)        0.010     0.022   0.176 (0.24)       0.474
   log⁡(Waist circumference)      0.094             0.82 (0.23)        0.001     0.017   0.165 (0.29)       0.573
   log⁡(Hip circumference)        0.034             0.68 (0.33)        0.042     0.016   −0.19 (0.39)       0.627
  log⁡(Triglyceride)                                                                                         
   log⁡(Neck circumference)       0.137             1.49 (0.46)        0.002     0.172   2.45 (0.82)        0.005
   log⁡(Body mass index)          0.089             0.56 (0.30)        0.064     0.145   1.379 (0.51)       0.010
   log⁡(Waist circumference)      0.087             0.73 (0.40)        0.070     0.138   1.562 (0.6)        0.012
   log⁡(Hip circumference)        0.094             1.12 (0.55)        0.042     0.094   1.691 (0.82)       0.044
  Total cholesterol                                                                                          
   log⁡(Neck circumference)       0.023             134.99 (85.59)     0.117     0.007   −69.724 (153.93)   0.653
   log⁡(Body mass index)          0.015             66.37 (54.09)      0.222     0.004   23.785 (91.82)     0.797
   log⁡(Waist circumference)      0.012             76.58 (72.20)      0.291     0.006   46.529 (109.06)    0.672
   log⁡(Hip circumference)        0.007             71.37 (99.35)      0.474     0.003   30.962 (146.12)    0.833
  LDL cholesterol                                                                                            
   log⁡(Neck circumference)       0.040             158.88 (72.59)     0.031     0.012   27.354 (141.34)    0.847
   log⁡(Body mass index)          0.048             109.69 (45.5)      0.017     0.030   80.653 (83.39)     0.338
   log⁡(Waist circumference)      0.023             99.41 (61.43)      0.108     0.017   51.923 (99.87)     0.606
   log⁡(Hip circumference)        0.009             84.18 (84.89)      0.323     0.016   66.655 (133.64)    0.620
  log⁡(HDL cholesterol)                                                                                      
   log⁡(Neck circumference)       0.008             −0.19 (0.29)       0.506     0.101   −0.936 (0.42)      0.032
   log⁡(Body mass index)          0.032             −0.33 (0.18)       0.071     0.023   −0.241 (0.26)      0.365
   log⁡(Waist circumference)      0.011             −0.22 (0.24)       0.376     0.024   −0.294 (0.31)      0.354
   log⁡(Hip circumference)        0.005             −0.14 (0.34)       0.688     0.017   −0.311 (0.43)      0.471

*R* ^2^: unadjusted *R* ^2^; *B*: unstandardized coefficients beta; SE: unstandardized coefficients Std. Error.

  Dependent variables             Men (*n* = 125)   Women (*n* = 52)                                      
  ------------------------------- ----------------- ------------------ --------- ------- ---------------- ---------
  24 hr CCR                                                                                                
   log⁡(Neck circumference)       0.642             260.86 (54.29)     \<0.001   0.340   169.5 (114.94)   0.147
   log⁡(Body mass index)          0.621             138.8 (35.39)      \<0.001   0.310   22.78 (72.38)    0.754
   log⁡(Waist circumference)      0.643             221.38 (45.7)      \<0.001   0.310   17.76 (83.87)    0.833
   log⁡(Hip circumference)        0.659             337.81 (61.38)     \<0.001   0.309   7.43 (112.11)    0.947
  eGFR~CG~                                                                                                 
   log⁡(Neck circumference)       0.867             200.2 (23.38)      \<0.001   0.800   193.98 (46.15)   \<0.001
   log⁡(Body mass index)          0.891             143.99 (13.43)     \<0.001   0.924   193.43 (17.47)   \<0.001
   log⁡(Waist circumference)      0.907             205.1 (16.53)      \<0.001   0.857   183.11 (27.77)   \<0.001
   log⁡(Hip circumference)        0.889             261.02 (24.76)     \<0.001   0.910   288.32 (29.52)   \<0.001
  eGFR~MDRD~                                                                                               
   log⁡(Neck circumference)       0.923             13.96 (14.05)      0.322     0.945   −7.1 (20.16)     0.726
   log⁡(Body mass index)          0.923             −11.03 (8.88)      0.217     0.945   3.87 (12.42)     0.757
   log⁡(Waist circumference)      0.922             9.6 (11.86)        0.420     0.946   12.38 (14.28)    0.391
   log⁡(Hip circumference)        0.923             20.57 (16.24)      0.208     0.946   −14.26 (19.12)   0.460
  log⁡(Cystatin C)                                                                                         
   log⁡(Neck circumference)       0.674             0.33 (0.2)         0.098     0.619   0.14 (0.34)      0.681 
   log⁡(Body mass index)          0.665             0.02 (0.12)        0.852     0.639   0.3 (0.2)        0.141
   log⁡(Waist circumference)      0.670             0.21 (0.17)        0.215     0.637   0.33 (0.23)      0.169
   log⁡(Hip circumference)        0.679             0.47 (0.22)        0.037     0.631   0.36 (0.3)       0.242
  Uric Acid                                                                                                
   log⁡(Neck circumference)       0.138             −3.49 (3.74)       0.353     0.346   17.8 (5.5)       0.002
   log⁡(Body mass index)          0.133             1.17 (2.3)         0.612     0.319   9.93 (3.46)      0.006
   log⁡(Waist circumference)      0.132             0.87 (3.08)        0.778     0.262   8.4 (4.17)       0.050
   log⁡(Hip circumference)        0.136             −3.34 (4.24)       0.432     0.296   13.84 (5.44)     0.014
  log⁡(Urine microalbuminuria)                                                                             
   log⁡(Neck circumference)       0.096             2.62 (1.46)        0.075     0.271   6.68 (2.1)       0.003
   log⁡(Body mass index)          0.168             3.24 (0.89)        \<0.001   0.168   2.47 (1.36)      0.077
   log⁡(Waist circumference)      0.142             3.64 (1.18)        0.003     0.191   3.35 (1.56)      0.037
   log⁡(Hip circumference)        0.134             4.74 (1.64)        0.005     0.145   3.02 (2.14)      0.164
  log⁡(hsCRP)                                                                                              
   log⁡(Neck circumference)       0.073             3 (1.39)           0.033     0.114   4.25 (1.97)      0.037
   log⁡(Body mass index)          0.094             2.3 (0.85)         0.008     0.072   1.92 (1.24)      0.127
   log⁡(Waist circumference)      0.085             2.85 (1.13)        0.014     0.074   2.26 (1.43)      0.121
   log⁡(Hip circumference)        0.073             3.44 (1.58)        0.031     0.104   3.82 (1.88)      0.048
  log⁡(Systolic blood pressure)                                                                            
   log⁡(Neck circumference)       0.017             0.14 (0.12)        0.248     0.028   0.14 (0.17)      0.388
   log⁡(Body mass index)          0.045             0.16 (0.07)        0.030     0.012   0.01 (0.1)       0.927
   log⁡(Waist circumference)      0.034             0.19 (0.1)         0.066     0.022   0.08 (0.12)      0.494
   log⁡(Hip circumference)        0.037             0.27 (0.14)        0.053     0.017   0.08 (0.16)      0.633
  Diastolic blood pressure                                                                                 
   log⁡(Neck circumference)       0.127             27.95 (19.83)      0.161     0.211   29.04 (29.34)    0.328
   log⁡(Body mass index)          0.169             35.02 (12.26)      0.005     0.197   8.09 (18.23)     0.659
   log⁡(Waist circumference)      0.132             27.86 (16.66)      0.097     0.227   28.83 (20.72)    0.171
   log⁡(Hip circumference)        0.139             43.71 (22.83)      0.058     0.240   45.54 (27.46)    0.104
  log⁡(Fasting plasma glucose)                                                                             
   log⁡(Neck circumference)       0.033             0.47 (0.29)        0.103     0.068   0.09 (0.41)      0.826
   log⁡(Body mass index)          0.061             0.45 (0.18)        0.014     0.068   0.08 (0.25)      0.765
   log⁡(Waist circumference)      0.100             0.8 (0.23)         0.001     0.069   0.1 (0.29)       0.733
   log⁡(Hip circumference)        0.041             0.64 (0.33)        0.055     0.077   −0.28 (0.38)     0.469
  log⁡(Triglyceride)                                                                                       
   log⁡(Neck circumference)       0.138             1.49 (0.46)        0.002     0.436   2.25 (0.69)      0.002
   log⁡(Body mass index)          0.090             0.57 (0.3)         0.061     0.355   0.92 (0.47)      0.056
   log⁡(Waist circumference)      0.088             0.74 (0.4)         0.068     0.384   1.27 (0.52)      0.018
   log⁡(Hip circumference)        0.095             1.14 (0.55)        0.040     0.351   1.32 (0.7)       0.067
  Total cholesterol                                                                                        
   log⁡(Neck circumference)       0.033             133.61 (85.5)      0.121     0.007   −71.5 (156.05)   0.649
   log⁡(Body mass index)          0.023             59.89 (54.46)      0.274     0.004   22.75 (96.28)    0.814
   log⁡(Waist circumference)      0.021             69.07 (72.53)      0.343     0.006   45.77 (111.37)   0.683
   log⁡(Hip circumference)        0.016             59 (99.97)         0.556     0.003   29.37 (149.02)   0.845
  LDL cholesterol                                                                                          
   log⁡(Neck circumference)       0.048             157.85 (72.6)      0.032     0.012   28.43 (143.31)   0.844
   log⁡(Body mass index)          0.052             105.66 (45.9)      0.023     0.033   88.74 (87.34)    0.315
   log⁡(Waist circumference)      0.029             94.18 (61.81)      0.130     0.017   54.16 (101.96)   0.598
   log⁡(Hip circumference)        0.016             75.3 (85.54)       0.381     0.017   69.33 (136.28)   0.613 
  log⁡(HDL cholesterol)                                                                                    
   log⁡(Neck circumference)       0.023             −0.2 (0.29)        0.494     0.202   −0.86 (0.4)      0.039
   log⁡(Body mass index)          0.051             −0.36 (0.18)       0.049     0.123   −0.07 (0.26)     0.782
   log⁡(Waist circumference)      0.028             −0.25 (0.24)       0.305     0.128   −0.18 (0.3)      0.562
   log⁡(Hip circumference)        0.022             −0.18 (0.34)       0.596     0.124   −0.15 (0.41)     0.724

*R* ^2^: unadjusted *R* ^2^; *B*: unstandardized coefficients beta; SE: unstandardized coefficients Std. Error.

[^1]: Academic Editor: Jamal H. Hashim
